Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03230578 · ClinicalTrials.gov registry record
Perspectives on Prescribing Hormonal Contraception Among Rural New Mexicans
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 60
- Enrollment target
NCT03230578: Completed study, sponsored by University of New Mexico.
NCT03230578 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03230578 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.
Primary Outcome
To explore pharmacist perspectives on providing prescriptions for hormonal contraceptives, specifically identifying perceived barriers and facilitators to implementation.
Interventions
- OTHER Pharmacists & women's perspectives on pharmacist prescribed hormonal contraception
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-11-14 |
| Est. Completion | 2018-06-08 |
What the finished NCT03230578 record still lists
NCT03230578 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Pharmacists & women's perspectives on pharmacist prescribed hormonal contraception is the first listed.
NCT03230578 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03230578 about?
NCT03230578 is a clinical study titled "Perspectives on Prescribing Hormonal Contraception Among Rural New Mexicans". The goal of this study is to identify the thoughts and perceptions of pharmacy access to hormonal contraception among rural women and pharmacists. This will be key in order to address concerns or perceived barriers in order to inform the implementation of this program.
What is the current status of trial NCT03230578?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2017-11-14. Estimated completion is 2018-06-08.
What interventions are being tested in trial NCT03230578?
The interventions under investigation include: Pharmacists & women's perspectives on pharmacist prescribed hormonal contraception (OTHER).
Who is sponsoring clinical trial NCT03230578?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI